Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Impact of COVID-19 on Access to HIV Prevention Services Among Opioid-Dependent Individuals
Colleen Mistler, Christine M. Curley, Aviana O. Rosen, et al.
Journal of Community Health (2021) Vol. 46, Iss. 5, pp. 960-966
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Impact of the COVID-19 pandemic on HIV testing rates across four geographically diverse urban centres in the United States: An observational study
Ethan Moitra, Jun Tao, Joseph Olsen, et al.
The Lancet Regional Health - Americas (2021) Vol. 7, pp. 100159-100159
Open Access | Times Cited: 51
Examining the impact of the first wave of COVID-19 and associated control measures on interventions to prevent blood-borne viruses among people who inject drugs in Scotland: an interrupted time series study
Kirsten M. A. Trayner, Andrew McAuley, Norah Palmateer, et al.
Drug and Alcohol Dependence (2022) Vol. 232, pp. 109263-109263
Open Access | Times Cited: 22
Mobile Health Technology Use and the Acceptability of an mHealth Platform for HIV Prevention Among Men Who Have Sex With Men in Malaysia: Cross-sectional Respondent-Driven Sampling Survey
Roman Shrestha, Francesca Maviglia, Frederick L. Altice, et al.
Journal of Medical Internet Research (2022) Vol. 24, Iss. 7, pp. e36917-e36917
Open Access | Times Cited: 21
HIV Testing Pre- and Post-COVID-19 Pandemic Among Persons who Inject Drugs – National HIV Behavioral Surveillance, 19 Cities, 2018 and 2022
Rebecca B. Hershow, Dita Broz, Lyssa Faucher, et al.
AIDS and Behavior (2025)
Closed Access
Impacts of the COVID-19 Pandemic on the HIV Care Continuum and Associated Factors in High-Income Nations: A Mixed-Methods Systematic Review
Emmanuela Ojukwu, Zahra Pashaei, Juliana Cunha Maia, et al.
AIDS and Behavior (2025)
Closed Access
Provider Perspectives on HIV Pre-Exposure Prophylaxis Service Disruptions and Adaptations During the COVID-19 Pandemic in Baltimore, Maryland: A Qualitative Study
Joseph G. Rosen, Leanne Zhang, Danielle Pelaez, et al.
AIDS Patient Care and STDs (2022) Vol. 36, Iss. 8, pp. 313-320
Open Access | Times Cited: 17
Characterizing the Impact of the COVID-19 Pandemic on HIV PrEP care: A Review and Synthesis of the Literature
Chenglin Hong
AIDS and Behavior (2022) Vol. 27, Iss. 7, pp. 2089-2102
Open Access | Times Cited: 16
Impact of COVID-19 & Response Measures on HIV-HCV Prevention Services and Social Determinants in People Who Inject Drugs in 13 Sites with Recent HIV Outbreaks in Europe, North America and Israel
Lucas Wiessing, Vana Sypsa, Adrian Abagiu, et al.
AIDS and Behavior (2022) Vol. 27, Iss. 4, pp. 1140-1153
Open Access | Times Cited: 15
Exploring the impact of the COVID-19 pandemic on healthcare and substance use service access among women who inject drugs: a qualitative study
Lyra Cooper, Joseph G. Rosen, Leanne Zhang, et al.
Harm Reduction Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 8
The impact of the COVID-19 pandemic on the provision of HIV/AIDS-related services in Iran: a qualitative study
Zahra Jaafari, Hossein Mirzaei, Yousef Moradi, et al.
BMC Health Services Research (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Economic Challenges and Behavioral and Mental Health Risks for Overdose during the COVID-19 Pandemic among People Who Inject Drugs
Leslie D. Williams, Eunhye Lee, Carl A. Latkin, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 9, pp. 5351-5351
Open Access | Times Cited: 12
Illicit Substance Use and the COVID-19 Pandemic in the United States: A Scoping Review and Characterization of Research Evidence in Unprecedented Times
Anh Truc Vo, Thomas Patton, Amy Peacock, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 14, pp. 8883-8883
Open Access | Times Cited: 12
Disruptions to HIV services due to the COVID pandemic in the USA: a state-level stakeholder perspective
Rogério M. Pinto, Evan Hall, Vitalis Im, et al.
BMC Health Services Research (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
A stakeholder-driven framework for measuring potential change in the health risks of people who inject drugs (PWID) during the COVID-19 pandemic
Heather Bradley, Chelsea Austin, Sean T. Allen, et al.
International Journal of Drug Policy (2022) Vol. 110, pp. 103889-103889
Open Access | Times Cited: 10
Race, trust, and COVID-19 vaccine hesitancy in people with opioid use disorder.
Matthew C. Sullivan, Colleen Mistler, Michael D. Miller, et al.
Health Psychology (2021) Vol. 41, Iss. 2, pp. 115-120
Open Access | Times Cited: 12
Factors associated with receptive injection equipment sharing among people who inject drugs: findings from a multistate study at the start of the COVID-19 pandemic
Sean T. Allen, Kristin E. Schneider, Miles Morris, et al.
Harm Reduction Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 4
‘Condoms are hard to get by’: access to HIV prevention methods during lockdown of the COVID-19 epidemic in eastern Zimbabwe
Morten Skovdal, Tanyaradzwa Maunzagona, Freedom Dzamatira, et al.
Global Health Action (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 4
“Maintaining HIV and HCV prevention and care for people who inject drugs despite COVID‐19 in Hai Phong, Vietnam”
Hoang Thi Giang, Nguyen Quang Duc, Jean‐Pierre Molès, et al.
International Journal of Drug Policy (2022) Vol. 110, pp. 103870-103870
Open Access | Times Cited: 6
Intersecting epidemics: the impact of coronavirus disease 2019 on the HIV prevention and care continua in the United States
Camille E. Spears, Barbara S. Taylor, Albert Liu, et al.
AIDS (2022) Vol. 36, Iss. 13, pp. 1749-1759
Open Access | Times Cited: 6
The impacts of COVID-19 on structural inequities faced by people living with HIV who inject drugs: A qualitative study in St. Petersburg, Russia
Jennifer Carroll, Sarah L. Rossi, Marina Vetrova, et al.
International Journal of Drug Policy (2023) Vol. 117, pp. 104060-104060
Open Access | Times Cited: 3
Evaluation of Trends in Preexposure Prophylaxis Prescriptions During the First 6 Months of the COVID-19 Pandemic in New York State
Thomas O’Grady, James M. Tesoriero, Yingchao Yuan, et al.
JAMA Network Open (2022) Vol. 5, Iss. 3, pp. e224065-e224065
Open Access | Times Cited: 4
Factors Associated with HIV Testing Among People Who Inject Drugs: Findings from a Multistate Study at the Start of the COVID-19 Pandemic
Sean T. Allen, Kristin E. Schneider, Miles Morris, et al.
AIDS and Behavior (2022) Vol. 27, Iss. 5, pp. 1674-1681
Open Access | Times Cited: 4
Protocol to implement a syndromic surveillance survey of COVID-19 in Malawi
Thulani Maphosa, Godfrey Woelk, Brittney Baack, et al.
Public Health in Practice (2022) Vol. 4, pp. 100339-100339
Open Access | Times Cited: 3
Prepandemic Predictors of Medication Adherence and HIV Viral Load During the First Year of COVID-19
Seth C. Kalichman, Lisa A. Eaton, Moira O. Kalichman, et al.
JAIDS Journal of Acquired Immune Deficiency Syndromes (2022) Vol. 92, Iss. 3, pp. 242-249
Open Access | Times Cited: 3
Program Director Reports of COVID-19 Lockdown-Driven Service Changes in Community-Based STI Clinics and Syringe Services Programs in the Southeastern U.S.
Mary A. Hatch, Tanja C. Laschober, Melissa M. Ertl, et al.
AIDS Education and Prevention (2024) Vol. 36, Iss. 2, pp. 129-140
Closed Access
Page 1 - Next Page

Scroll to top